Clinical and Microbiologic Features Guiding Treatment Recommendations for Brain Abscesses in Children
Authors:
- Bhanu WilliamsBWBhanu Williams
- Delane ShingadiaDSDelane Shingadia
- Lucy CoxonLCLucy Coxon
- Andrew RiordanARAndrew Riordan
- Andreas K. DemetriadesADAndreas K. Demetriades
- Christopher L. ChandlerCCChristopher L. Chandler
- Sanj BassiSBSanj Bassi
- Eirini KoutoumanouEKEirini Koutoumanou
- Simon StapletonSSSimon Stapleton
- Mike SharlandMSMike Sharland
- Penelope A. BryantPBPenelope A. Bryant
- 1 February 2013
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 32 (2) , 129-135
Abstract
There are no guidelines for the management of brain abscesses in children, and there is a paucity of recent data describing clinical and microbiologic features. We aimed to identify factors affecting outcome to inform antibiotic recommendations. From 1999 to 2009, 118 children presented with brain abscesses to 4 neurosurgical centers in the United Kingdom. Clinical, microbiologic and treatment data were collected. The commonest preceding infection was sinusitis, with 59% of all children receiving antibiotics before diagnosis. Nonspecific symptoms were common, with only 13% having the triad of fever, headache and focal neurological deficit. Time between symptom onset and diagnosis varied widely (median, 10 days; range, 0-44). Magnetic resonance imaging was more frequently diagnostic than computed tomography. The most frequent organisms were Streptococcus milleri (38%), except after penetrating head injury or neurosurgery, for which Staphylococcus aureus was most common. The commonest empiric antibiotics were ceftriaxone/cefotaxime and metronidazole, which offered effective antimicrobial therapy in up to 83% of cases. Metronidazole added benefit in a maximum of 7% of cases, with ceftriaxone/cefotaxime alone sufficient in at least 76% and in all cases with cyanotic congenital heart disease or meningitis. A carbapenem would have been effective in 90%. The case fatality rate was 6% (33% in the immunocompromised). Long-term neurological sequelae affected 35%. Age younger than 5 years and a Glasgow Coma Scale score ≤8 were associated with poor outcome at 6 months. We recommend ceftriaxone/cefotaxime and metronidazole as empiric treatment, although metronidazole may be unnecessary in many cases, with antistaphylococcal cover in cases of head trauma. Meropenem potentially would be a better choice in the immunocompromised. A prospective study of intravenous and oral treatment guided by clinical improvement is required beause 1-2 weeks of intravenous antibiotics during a total of 6 weeks may be sufficient in children.Keywords
This publication has 28 references indexed in Scilit:
- Brain abscess in children – epidemiology, predisposing factors and management in the modern medicine eraActa Paediatrica, 2010
- Brain abscess in Korean children: A 15-year single center studyKorean Journal of Pediatrics, 2010
- Management of brain abscesses in childrenNeurosurgical Focus, 2008
- Intracerebral Abscess in Children: Historical Trends at Children’s Hospital BostonPediatrics, 2004
- Management of brain abscesses in childrenThe Pediatric Infectious Disease Journal, 2004
- Brain abscess in childrenSeminars in Pediatric Infectious Diseases, 2003
- Management of Brain Abscesses with Sequential Intravenous/Oral Antibiotic TherapyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2000
- Outcome of Medical Treatment of Bacterial Abscesses Without Therapeutic Drainage: Review of Cases Reported in the LiteratureClinical Infectious Diseases, 1996
- Management of brain abscess in children: review of 130 cases over a period of 21 yearsChild's Nervous System, 1992
- Brain AbscessMedical Clinics of North America, 1985